427 related articles for article (PubMed ID: 17683826)
1. Biodegradable nanoparticles for cytosolic delivery of therapeutics.
Vasir JK; Labhasetwar V
Adv Drug Deliv Rev; 2007 Aug; 59(8):718-28. PubMed ID: 17683826
[TBL] [Abstract][Full Text] [Related]
2. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
4. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
Fredriksen BN; Grip J
Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
[TBL] [Abstract][Full Text] [Related]
5. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension.
Ishihara T; Hayashi E; Yamamoto S; Kobayashi C; Tamura Y; Sawazaki R; Tamura F; Tahara K; Kasahara T; Ishihara T; Takenaga M; Fukuda K; Mizushima T
J Control Release; 2015 Jan; 197():97-104. PubMed ID: 25449809
[TBL] [Abstract][Full Text] [Related]
7. Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticles.
Ishihara T; Takahashi M; Higaki M; Mizushima Y
Int J Pharm; 2009 Jan; 365(1-2):200-5. PubMed ID: 18804157
[TBL] [Abstract][Full Text] [Related]
8. [Current status and perspective of research on PEG-PLGA].
Zhou HN; Li YM; Liu T
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):561-3. PubMed ID: 21122404
[No Abstract] [Full Text] [Related]
9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
10. Design of biodegradable particles for protein delivery.
Vila A; Sánchez A; Tobío M; Calvo P; Alonso MJ
J Control Release; 2002 Jan; 78(1-3):15-24. PubMed ID: 11772445
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
Panyam J; Labhasetwar V
Adv Drug Deliv Rev; 2003 Feb; 55(3):329-47. PubMed ID: 12628320
[TBL] [Abstract][Full Text] [Related]
13. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
14. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
15. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.
Vandorpe J; Schacht E; Dunn S; Hawley A; Stolnik S; Davis SS; Garnett MC; Davies MC; Illum L
Biomaterials; 1997 Sep; 18(17):1147-52. PubMed ID: 9259511
[TBL] [Abstract][Full Text] [Related]
16. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
Sheng Y; He H; Zou H
Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
[TBL] [Abstract][Full Text] [Related]
17. Concepts and practices used to develop functional PLGA-based nanoparticulate systems.
Sah H; Thoma LA; Desu HR; Sah E; Wood GC
Int J Nanomedicine; 2013; 8():747-65. PubMed ID: 23459088
[TBL] [Abstract][Full Text] [Related]
18. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
Crotts G; Park TG
J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits.
Musumeci T; Bucolo C; Carbone C; Pignatello R; Drago F; Puglisi G
Int J Pharm; 2013 Jan; 440(2):135-40. PubMed ID: 23078856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
